======= MKLN1 ======= == Gene Information == * **Official Symbol**: MKLN1 * **Official Name**: muskelin 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4289|4289]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9UL63|Q9UL63]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MKLN1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MKLN1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605623|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Acts as a mediator of cell spreading and cytoskeletal responses to the extracellular matrix component THBS1. {ECO:0000250|UniProtKB:O89050}. |F5 F8 type C| |Muskelin N| |regulation of receptor internalization| |actin cytoskeleton reorganization| |ruffle| |regulation of receptor-mediated endocytosis| |ubiquitin ligase complex| |cell-matrix adhesion| |cell cortex| |regulation of cell shape| |cell-substrate adhesion| |regulation of endocytosis| |synapse| |regulation of cell morphogenesis| |actin cytoskeleton organization| |cell junction| |regulation of vesicle-mediated transport| |actin filament-based process| |protein homodimerization activity| |cell adhesion| |biological adhesion| |regulation of anatomical structure morphogenesis| |cytoskeleton organization| |regulation of transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp75|MK-1775 0.32μM R02 exp75]]|-3.54| |[[:results:exp147|Resveratrol 16μM R03 exp147]]|-2.39| |[[:results:exp526|Sulforaphane 9μM R08 exp526 no dilution day6]]|-2.16| |[[:results:exp355|Dinaciclib 0.007μM R07 exp355]]|-2.13| |[[:results:exp81|Selumetinib 20μM R02 exp81]]|-2.09| |[[:results:exp52|Ribavirin 10μM R01 exp52]]|-1.97| |[[:results:exp82|Torin1 0.08μM R02 exp82]]|-1.89| |[[:results:exp463|Caffeine 2600μM R08 exp463]]|-1.85| |[[:results:exp72|LB-100 4.1μM R02 exp72]]|-1.85| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|-1.81| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|-1.81| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|-1.71| |[[:results:exp15|Cycloheximide 0.2μM R00 exp15]]|1.75| |[[:results:exp537|WNT3A 44ng/ml R08 exp537]]|1.76| |[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|1.8| |[[:results:exp485|GSK626616 14μM R08 exp485]]|2.43| |[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|3.04| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 5385 * **Expression level (log2 read counts)**: 6.45 {{:chemogenomics:nalm6 dist.png?nolink |}}